COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,946 Articles (22,604 medRxiv, 8,342 bioRxiv)

Most recent first Previous |  Page 483: Articles 4821-4830  | Next

T492I mutation alters SARS-CoV-2 properties via modulating viral non-structural proteins
Lin, X., Sha, Z., Trimpert, J., Kunec, D., Jiang, C., Xiong, Y., Xu, B., Zhu, Z., Xue, W., Wu, H.
10.1101/2023.01.15.524090 — Posted: 2023-01-17
Maintained imbalance of triglycerides, apolipoproteins, energy metabolites and cytokines in long-term COVID-19 syndrome (LTCS) patients
Berezhnoy, G., Bissinger, R., Liu, A., Cannet, C., Schaefer, H., Kienzele, K., Bitzer, M., Haeberle, H., Goepel, S., Trautwein, C., Singh, Y.
10.1101/2023.01.13.523998 — Posted: 2023-01-17
Redistribution and activation of CD16brightCD56dim NK cell subset to fight against Omicron subvariant BA.2 after COVID-19 vaccination
Liu, Y., Peng, H., Xiang, T., Xu, F., Jiang, Y., Zhong, L., Peng, Y., Le, A., Zhang, W.
10.1101/2023.01.13.524025 — Posted: 2023-01-17
SARS-CoV-2 Envelope protein triggers depression and dysosmia via TLR2 mediated neuroinflammation
Su, W., Ju, J., Gu, M.-h., Wang, X., Liu, S., Yu, J., Mu, D.
10.1101/2023.01.15.524078 — Posted: 2023-01-17
The emergence of goblet inflammatory or ITGB6hi nasal progenitor cells determines age-associated SARS-CoV-2 pathogenesis
Woodall, M., Cujba, A.-M., Worlock, K. B., Case, K.-M., Masonou, T., Yoshida, M., Polanski, K., Huang, N., Lindeboom, R. G., Mamanova, L., Bolt, L., Richardson, L., Ellis, S., Palor, M., Burgoyne, T., Pinto, A., Moulding, D. A., McHugh, T. D., Saleh, A., Kilich, E., Mehta, P., O'Callaghan, C., Zhou, J., Barclay, W., De Coppi, P., Butler, C. R., Vinette, H., Roy, S., Breuer, J., Chambers, R. C., Heywood, W. E., Mills, K., Hynds, R. E., Teichmann, S. A., Meyer, K. B., Nikolic, M. Z., Smith, C. M.
10.1101/2023.01.16.524211 — Posted: 2023-01-17
Enhanced transmissibility, infectivity and immune resistance of the SARS-CoV-2 Omicron XBB.1.5 variant
Uriu, K., Ito, J., Zahradnik, J., Fujita, S., Kosugi, Y., Schreiber, G., The Genotype to Phenotype Japan (G2P-Japan) Consortium, , Sato, K.
10.1101/2023.01.16.524178 — Posted: 2023-01-17
Therapeutic and vaccine-induced cross-reactive antibodies with effector function against emerging Omicron variants
Addetia, A., Piccoli, L., Case, J. B., Park, Y.-J., Beltramello, M., Guarino, B., Dang, H., Pinto, D., Scheaffer, S., Sprouse, K., Bassi, J., Silacci-Fregni, C., Muoio, F., Dini, M., Vincenzetti, L., Acosta, R., Johnson, D., Subramanian, S., Saliba, C., Giurdanella, M., Lombardo, G., Leoni, G., Culap, K., McAlister, C., Rajesh, A., Dellota, E., Cameroni, E., Whitener, B., Giannini, O., Ceschi, A., Ferrari, P., Franzetti-Pellanda, A., Biggiogero, M., Garzoni, C., Zappi, S., Bernasconi, L., Kim, M. J., Schnell, G., Czudnochowski, N., Franko, N., Logue, J. K., Yoshiyama, C., Stewart, C., Chu, H., Schmid, M. A., Purcell, L. A., Snell, G., Lanzavecchia, A., Diamond, M., Corti, D., Veesler, D.
10.1101/2023.01.17.523798 — Posted: 2023-01-17
Coverage of primary and booster vaccination against COVID-19 by socioeconomic level: A nationwide cross-sectional registry study
Hansen, B. T., Labberton, A. S., Kour, P., Kraft, K. B.
10.1101/2023.01.13.23284467 — Posted: 2023-01-14
Occupational Determinants of COVID-19 Cumulative Incidence and Vaccination Rate in the United States
Ji, J. S., Duncan, D. T.
10.1101/2023.01.13.22274536 — Posted: 2023-01-14
SARS-CoV-2 VARIANT PREVALENCE ESTIMATION USING WASTEWATER SAMPLES
Lopez-de-Ullibarri, I., Tomas, L., Trigo-Tasende, N., Freire, B., Vaamonde, M., Gallego-Garcia, P., Barbeito, I., Vallejo, J. A., Tarrio-Saavedra, J., Alvarino, P., Beade, E., Estevez, N., Rumbo-Feal, S., Conde-Perez, K., De Chiara, L., Iglesias-Corras, I., Poza, M., Ladra, S., Posada, D., Cao, R.
10.1101/2023.01.13.23284507 — Posted: 2023-01-14

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).